Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group

August 14, 2026 9:28 AM
Bernstein SocGen Group analyst Jeffrey Walch raised the price target on Regeneron Pharma (NASDAQ: REGN) to $756.00 (from $753.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change